Repurposing of HIV/HCV protease inhibitors against SARS-CoV-2 3CLpro
Ling Ma, Quanjie Li, Yongli Xie, Jian‐Yuan Zhao, Dongrong Yi, Saisai Guo, Fei Guo, Jing Wang, Long Yang, Shan Cen
Topics & Concepts
ProteaseBiologyProteasesSimeprevirEnzymeVirologyIn vitroVirusBiochemistryMicrobiologyChemistryHepatitis C virusRibavirinComputational Drug Discovery MethodsSARS-CoV-2 and COVID-19 ResearchPARP inhibition in cancer therapy